Navigation Links
BioMotiv Secures $21 million in Initial Funding
Date:9/5/2012

CLEVELAND, Sept. 5, 2012 /PRNewswire/ -- BioMotiv today announced that it has secured $21 million in financing from its founding investors, University Hospitals and the Harrington Family. 

"BioMotiv is a new model for accelerating breakthrough discoveries into medicines and aligning capital and collaborations to develop a portfolio of therapeutics," said Baiju R. Shah, Chief Executive Officer of BioMotiv.  "Through their commitment, University Hospitals and the Harrington family have once again demonstrated their dedication to solving a major national challenge that prevents promising discoveries from advancing to patient benefit."

"The challenge of translating discoveries into clinical development requires an innovative, next-generation business model," said Ron Harrington, a successful entrepreneur and recognized philanthropist. "BioMotiv's mission-aligned model and experienced team will enable it to efficiently and effectively manage a portfolio of early-stage drugs."

BioMotiv is the mission-driven, for-profit therapeutic accelerator affiliated with The Harrington Project for Discovery and Development, a $250 million initiative announced by University Hospitals this past February. "Our mission is 'To Heal. To Teach. To Discover.,'" said Achilles A. Demetriou, MD, PhD, Chief Operating Officer of University Hospitals.  "The project, supported by the generosity of the Harrington family, is a national initiative to advance the standard of care by creating structures that support physician-scientists in developing their insights into new therapies."

The initial capital will be used to launch operations and initiate the development of BioMotiv's technology portfolio which is being sourced from leading academic medical centers and industry sources from across the country.  The company plans to raise a total of $100 million in capital.

About The Harrington Project for Discovery and Development

The Harrington Project for Discovery and Development (The Harrington Project), announced in late February, is a $250 million national initiative to support the discovery and development of breakthrough discoveries by physician-scientists.  The Harrington Project, centered at University Hospitals Case Medical Center, is a new and powerful national model that addresses a set of major challenges in advancing medicine.  It includes the UH Harrington Discovery Institute, a national Innovation Support Center, and BioMotiv. The project, powered by a generous gift and investment from the Harrington family, successful entrepreneurs and recognized philanthropists in Cleveland, provides a comprehensive model to advance discoveries into development and to create novel therapies for patient care.

For more information about The Harrington Project and the UH Harrington Discovery Institute, go to: UHHarringtonDiscoveryInstitute.org.

For more information about BioMotiv, go to: www.BioMotiv.com.


'/>"/>
SOURCE BioMotiv
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BioMotiv Names New Chief Executive Officer
2. Delcath Systems, Inc. Secures $20 Million Credit Facility
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Benvenue Medical Secures $25 Million Series D Financing
5. PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital
6. Dr. Jills Foot Pads Secures GSA Schedule and Expands to Service VA and Federal Agencies
7. Alexza Secures a $20 Million Committed Equity Financing Facility with Azimuth Opportunity, L.P.
8. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
9. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
10. Arthrosurface Hits a $100 Million Milestone
11. Vermillion Sets First Quarter 2012 Conference Call for Tuesday, May 15, 2012 at 4:30 p.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... Dublin ... of the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global ... including its applications in various applications. The report deals ... three main industries: pharmaceutical and biotechnology, food and beverage, ...
Breaking Medicine Technology:
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):